Does Medical Marijuana Have Any Benefits for ADHD?
Does medical marijuana help ADHD? No benefit has been proven: a 2017 trial of a THC and CBD spray in 30 adults missed its main goal, and no children were studied. Medical marijuana is being used for more conditions, though NIH says good evidence exists for only a few, and research on many others is at an early stage.
Many people ask what medical marijuana does for ADHD symptoms. Below we cover the research, the risks for young people and drug interactions. One point to keep in mind: CDC notes cannabis can impair attention.
What is ADHD?
ADHD is common in both children and adults.
In the United States, about 7 million children aged 3 to 17 (11.7%) have a current ADHD diagnosis, according to CDC, as do an estimated 15.5 million adults (6.0%). ADHD can make it hard to sit still, stay quiet or keep focus, so people with it may fidget or seem restless.
ADHD has a big impact on work and school life and can also make social interactions tough. While the condition is often treated with Ritalin or Adderall, some people with ADHD say they use cannabis instead.
One theory is that dopamine signaling works differently in people with ADHD. MedlinePlus says methylphenidate (Ritalin) works by changing the amounts of certain natural substances in the brain. Some people believe marijuana does something similar with fewer side effects, but the trial evidence below has not shown that.
What Does Research Show About Marijuana and ADHD?
Research on medical marijuana for ADHD is still small. Some people ask whether certain strains such as sativa or indica suit ADHD better, but the 2017 trial tested a THC and CBD spray, not strains.
Surveys of adults with ADHD show that some use cannabis to self-treat symptoms, according to the 2017 trial’s authors.
On its main measure, the spray in that trial had no significant effect, and small gains in hyperactivity did not hold up after statistical correction.
There is not enough research for doctors to recommend cannabis for ADHD. Research is growing, but the randomized trial evidence so far does not show that cannabis improves ADHD symptoms.
Can Medical Cannabis Help Patients with ADHD?
Not on current evidence. The dopamine idea described above has not been shown to treat ADHD. The 2017 trial did not show reliable short-term relief of ADHD symptoms from cannabis.
Some people with ADHD, mostly adults, use cannabis on their own and say it helps. Those are personal reports, not trial results, and legal access in more states has not changed that.
No cannabis product is FDA-approved to treat ADHD, and the risks for young people are covered below.
Responses to cannabis differ from person to person, so one person’s good experience, however real to them, cannot show that cannabis treats ADHD.
Are there any risks?
Cannabis carries specific risks for young people and possible interactions with ADHD medicine. Whether cannabis leads to other drug use is debated; NIDA notes that cannabis, alcohol and tobacco are usually the first substances people try.
Cannabis use carries particular risks for children and young teens. Research links cannabis use that starts in adolescence to lasting effects on thinking. A study following 1,037 people from birth found that persistent cannabis use starting in adolescence was linked to a decline in thinking skills by age 38. The 2017 trial studied adults only, and in Florida any certification for a patient under 18 needs a second physician to agree and a parent or guardian’s written consent.
Drug interactions are the second concern, and questions can arise with some ADHD medicines. Methylphenidate (MPH) already carries heart warnings, and the FDA says CBD can change how other drugs work, so ask your prescriber before combining cannabis with any ADHD medicine.
More research is needed; for now the evidence that cannabis helps ADHD is anecdotal.
Last updated October 16, 2026 by the Dr. Green Relief Editorial Team.
Medical review
Medically reviewed by Achilles Kalnoky, M.D.
Reviewed on .
He is licensed in Florida as a medical doctor, license ME115088, which you can check on the Florida Department of Health license lookup.
His review covers the medical statements in this post and the sources cited for them.
Sources
- NCCIH. Cannabis (Marijuana) and Cannabinoids: What You Need To Know
- NIMH. Attention-Deficit/Hyperactivity Disorder
- CDC. Cannabis Facts and Stats (March 7, 2025)
- CDC. Data and Statistics on ADHD (July 8, 2026)
- Staley BS et al. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults: National Center for Health Statistics Rapid Surveys System, United States, October-November 2023. MMWR Morb Mortal Wkly Rep. 2024 (PubMed)
- MedlinePlus. Methylphenidate
- Cooper RE et al. Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. Eur Neuropsychopharmacol. 2017 (PubMed)
- NIDA. Cannabis (Marijuana)
- Meier MH et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012 (PubMed)
- FDA. What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD
- The 2026 Florida Statutes, s. 381.986, Medical use of marijuana (Florida Senate)
